SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001420720-08-000025
Filing Date
2008-09-29
Accepted
2008-09-29 15:58:15
Documents
21
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 inb210k_20080730.htm 10-K 432151
2 exhibit21.htm EX-21 1192
3 exhibit31_1.htm EX-31 9131
4 exhibit31_2.htm EX-31 9176
5 exhibit32_1.htm EX-32 6262
6 exhibit32_2.htm EX-32 5763
7 GRAPHIC image002.gif GRAPHIC 5159
8 GRAPHIC image004.gif GRAPHIC 1323
9 GRAPHIC image006.gif GRAPHIC 2121
10 GRAPHIC image008.gif GRAPHIC 14721
11 GRAPHIC image010.gif GRAPHIC 10202
12 GRAPHIC image012.gif GRAPHIC 6642
13 GRAPHIC image014.gif GRAPHIC 5850
14 GRAPHIC image016.gif GRAPHIC 11585
15 GRAPHIC image018.gif GRAPHIC 2248
16 GRAPHIC image020.gif GRAPHIC 1716
17 GRAPHIC image022.gif GRAPHIC 3074
18 GRAPHIC image024.gif GRAPHIC 1743
19 GRAPHIC image026.gif GRAPHIC 2184
20 GRAPHIC image028.gif GRAPHIC 5804
21 GRAPHIC image030.gif GRAPHIC 5246
  Complete submission text file 0001420720-08-000025.txt   576956
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBioPharma, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-53125 | Film No.: 081094357
SIC: 2834 Pharmaceutical Preparations